Healthcare & Biotech

New York – September 30, 2026 -- Researchers at NYU Langone Health have built an artificial intelligence system that tracks the daily case exposure of radiology residents and flags missing pathologies with more than 90 percent accuracy, according to a study published online in Academic Radiology.

AI system pinpoints training gaps that traditional case logs miss

The tool monitors which conditions residents encounter during clinical rotations and automatically identifies underexposed pathologies, then assigns supplemental teaching cases to close the gap. Study author Vinay Prabhu, an associate professor in NYU Grossman School of Medicine's Department of Radiology, said residents seeing 30 cases in a day typically encounter 29 routine exams and only one uncommon condition, leaving gaps in exposure to rarer diseases they will face throughout their careers.

UNITED STATES – September 30, 2026 -- ProgenyHealth has appointed Melanie Bella to its Board of Managers and named Alec DiDonato as Chief Operating Officer, moves the maternity and NICU care management company says will support its national expansion.

Bella brings 25 years of Medicaid policy experience to the board

Bella, an Executive Advisor with Cressey & Company, previously chaired the Medicaid and CHIP Payment and Access Commission (MACPAC). She served as Executive Vice President of Policy and Duals Strategy at Cityblock Health, a value-based provider focused on Medicaid and dual-eligible populations, and was the first Director of the Medicare-Medicaid Coordination Office at the Centers for Medicare & Medicaid Services. She also served as Medicaid Director for the state of Indiana and holds an MBA from Harvard Business School and a bachelor's degree from DePauw University.

Lisle, Ill. – – September 30, 2026 -- Forum Health, LLC has appointed Elizabeth Campbell as Chief Financial and Development Officer, a newly created role tasked with leading fundraising and acquisitions as the functional medicine network pursues rapid expansion.

Campbell joins after building and selling a 88-clinic orthodontic platform

Campbell co-founded myOrthos, LLC in 2019 and served as CEO, completing 37 acquisitions to build a platform of 88 clinics across 14 states before its 2025 sale to Smile Doctors, a portfolio company of TH Lee. She brings more than 20 years of experience spanning The Boston Consulting Group, private equity roles at SV Life Sciences Advisors and LLR Partners, and healthcare operating leadership.

New York – September 30, 2026 -- Direct-to-patient healthcare company Ro presented the first real-world evidence on Novo Nordisk's oral Wegovy pill at the EASD2026 meeting in Milan on September 30, based on outcomes from patients on its platform who switched from an injectable GLP-1.

Ro's platform generates first clinical data on Wegovy pill switch patients

The short oral session study, co-authored by Ro clinical advisors Dr. Beverly Tchang and Dr. Louis Aronne, tracked patients with overweight or obesity who transitioned from an injectable GLP-1 and remained persistent with the Wegovy pill for three months on Ro's platform.

Berlin – – September 30, 2026 -- TIB MOLBIOL, a subsidiary of Roche Diagnostics, has launched the LightMix® Newborn TREC/SMN1/HBB kit, an IVDR-approved in vitro diagnostic test that simultaneously screens newborns for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD) in countries accepting the CE mark.

Single kit consolidates three critical newborn screening panels for hospital labs

The test runs on established LightCycler systems, giving private and academic hospital laboratories a ready-to-use solution that integrates into existing workflows without requiring new infrastructure investment.

Los Angeles – September 30, 2026 -- The California Consortium of Addiction Programs and Professionals (CCAPP) will run its 13th Annual California Addiction Conference (CAC) from October 14-18, 2026, at the Sheraton Universal Hotel in Universal City, consolidating three previously separate summits into a single five-day program.

Bridgeport, W. Va. – September 29, 2026 -- Pressley Ridge convened more than 50 community partners, advocates, and child welfare experts at the Bridgeport Conference Center from September 15 to 18 for the B~Hope Conference and Summit, focused on advancing kinship care and family-centered support across West Virginia.

Conference spotlights two family-support frameworks

Sessions centered on the Family Centered Treatment Foundation® (FCT) model alongside the newly introduced Pressley Ridge B~Hope Embracing Kinship Caregivers curriculum, both aimed at equipping caregivers and families with practical resources to sustain kinship placements.

Woburn, Mass. – – September 29, 2026 -- Cytrellis Biosystems, Inc. has signed a commercialization agreement with KoreAx Co. Ltd. to launch its ellacor skin-removal device in South Korea, marking the company's second international market entry of 2026 after Australia.

South Korea's Ministry of Food and Drug Safety cleared ellacor in 2025

Ellacor is described as the first and only FDA-cleared, minimally invasive, in-office procedure that removes sagging skin without surgery or thermal energy. The device uses Micro-Coring technology and is approved for adults aged 22 and older with Fitzpatrick skin types I-IV.

Shreveport, La. – September 29, 2026 -- Pathology Ventures, LLC (PVL), a physician-founded network representing more than 500 pathologists, has appointed Dominic Stockey as executive vice president to lead partnerships with pharmaceutical, diagnostic and research sponsors.

Former investment banker to run sponsor and enterprise development

Stockey joins PVL after seven years in investment banking, where he served as Vice President and worked on more than 15 closed transactions across diagnostics, life sciences and healthcare, including mergers and acquisitions and capital formation deals. At PVL, he will oversee business operations, sponsor and partner relationships, commercialization, contracting and program execution.

New York – – September 29, 2026 -- Dimora Medical unveiled a silicone foam wound dressing built on its MegaSorbTM Dual-Action Absorption System, targeting moderate to heavy exudate wounds common among elderly patients with pressure ulcers and chronic wounds. The launch coincides with the 2026 United Nations International Day of Older Persons, observed under the theme "The Age of Longevity: Rethinking Systems for Longer Lives."

MegaSorb foam absorbs up to 15 times its own weight in wound exudate

The dressing uses a high-porosity polymer with an open-cell structure reaching up to 90%, enabling it to lock in exudate within one second and reduce leakage and backflow risk. Dimora Medical positions the technology as a direct response to gaps in traditional wound dressings, which frequently fail to manage moderate to heavy exudate, causing maceration of surrounding skin and painful dressing changes.